Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2012 results



At its meeting of March 13, 2013, the Board of Directors of Boiron, chaired by Thierry Boiron, approved the statutory and consolidated financial statements as of December 31, 2012. It was decided to call a combined Shareholders Meeting on May 23, 2013 at the Company's headquarters in Sainte-Foy-lès-Lyon.


Audits of the statutory and consolidated financial statements have been performed and the audit reports concerning their certification are currently in the process of being issued.


 


BOIRON GROUP RESULTS














































(in thousands of euros) 2011 2012 Change

2012/2011
Sales 523,215 566,294 +8.2%
Operating Income 63,695 81,109 +27.3%
Net Income - group share 42,248 49,626 +17.5%
Cash Flow 86,045 114,736 +33.3%
Net Investments 53,172 19,135 -64.0%
Net Cash position 89,801 94,704 +5.5%


  • The profitability has improved due in particular to the price increase of certain non proprietary medicines in France and the control of operating costs.


  • On December 31, 2012, the cash position amounted € 94.7 million given the lower amount of net investments compared to 2011 and the buyback of Boiron shares from Pierre Fabre SA for an amount of € 51.0 million.


  • The Board of Directors will propose to the Combined Shareholders Meeting the distribution of a dividend of € 0.90 per share. The payment of the dividend will be June 5, 2013. 


  • In the first quarter of 2013, the business is expected to grow significantly due to the high level of winter pathology.


  • In 2013, Boiron targets a new increase of its turnover and profitability.

 


Our next update:

April 23, 2013, at market close, publication of quarterly sales and financial information as of March 31, 2013.

Person responsible for financial information: Philippe Montant

Contact for financial information: Véronique Bouscayrol

Investor relations: +33 (0)4.78.45.63.43 - Email: [email protected]

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at : www.boiron.com


Information réglementée
Communiqués au titre de l'obligation d'information permanente :

- Communiqué sur comptes, résultats, chiffres d'affaires

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-31236-cp-boiron-130313.pdf

<!-- 90 -->

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free


<br/><p>Quelle: <a href="http://www.actusnews.com/" target="_blank" rel="nofollow">Actusnews</a></p>

Boiron S.A. Stock

€32.10
-1.530%
We can see a decrease in the price for Boiron S.A.. Compared to yesterday it has lost -€0.500 (-1.530%).

Like: 0
Share

Comments